Market Research Reports
Resources
About
Cart (0)

Cardiovascular Surgical Devices: The Global Market

Report Code: HLC076A

Publish Date: Oct 2010

Publisher: BCC Publishing

Category: Health Maintenance

Customize This Report

Single User License: $2500

Member Price: FREE

EXPLORE OFFERS

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

  • The global market for cardiovascular surgical devices used in the operating room is worth an estimated $31 billion in 2010. By 2015, this market will be valued at nearly $48 billion, a compound annual growth rate (CAGR) of 8.7%.
  • Despite significant growth in interventional cardiac surgery procedures, the traditional cardiac surgical device market is expected to expand faster, primarily driven by the growth in cardioprosthetics such as ventricular assist devices. This sector is worth an estimated $7 billion in 2010 and is expected to increase at a 10.9% compound annual growth rate (CAGR) to reach $12 billion in 2015.
  • The second fastest area of growth is in cardiac rhythm management devices, particularly for the treatment of atrial fibrillation (AF). This sector is valued at $11 billion in 2010 and is expected to be worth $18 billion in 2015, a compound annual growth rate (CAGR) of 10.2%.

INTRODUCTION

STUDY GOALS AND OBJECTIVES

The goal of this study is to explore the different factors affecting cardiovascular surgery and the manufacture of cardiovascular devices. Cardiac surgery is on the rise globally, with macroeconomic factors such as aging populations; increased obesity, poor nutrition, and other heart-health stressors; and the technological maturity of devices that make sophisticated treatments feasible for patients in previously inaccessible populations.

Whether through disease, congenital defects, or generalized degradation of cardiological function over time, cardiovascular diseases are increasing dramatically, substantiating the need for continued growth of cardiovascular surgery.
 
REASONS FOR DOING THIS STUDY
 
According to statistics from the American Medical Association (AMA), more than 80 million people suffer from some form of heart disease. While cardiovascular surgery has long been practiced, recent innovations such as minimally invasive procedures, “beating heart” surgeries, cardiac rhythm management (CRM), and other procedural improvements have become treatments that create fewer side effects for patients and less time spent in post-surgical recovery.
 
Newer cardiovascular devices and procedures play a large part in enhancing the quality of life for an increasingly elderly population, as well as populations with poor cardiac function and other heart-related diseases. The ability of government-run health agencies and private insurers to cope with the increasing need for cardiovascular procedures and the skyrocketing costs involved have lead agencies and insurers alike to consider their payments surrounding necessary medical procedures and, consequently, cardiovascular surgical procedures.
 
This report will identify areas of growth within the cardiovascular surgical equipment market and identify companies offering innovative equipment relating to cardiovascular devices. Growth will be projected on manufacturers’ net revenues, unless otherwise indicated.
 
This report is designed to achieve the following objectives: 
  • Describe the trends and developments for each type of cardiovascular surgical technology and how each is meant to meet marketplace needs.
  • Analyze market and driving forces to project market size for the technologies and pinpoint target applications.
  • Examine the cardiovascular surgical business in terms of companies and their position in the market.
The report is designed to appeal to many different readers, including venture capitalists interested in exploring commercialization opportunities, marketing, and management individuals within the industry, and even the novice reader, who desires to understand how market pressures and technology interact in this industry.
 
SCOPE OF REPORT
 
The scope of this study encompasses multiple technologies and procedures related to cardiovascular surgical devices. The study focuses on several different types and categories of cardiovascular surgery involving traditional, interventional, and CRM devices, categorized logically so that comparisons can be made within diagnostic and procedural groups as well as across the cardiovascular surgical device industry as a whole.
 
BCC analyzes the industry on a worldwide basis from market, product, and technology perspectives. Regulations and reimbursement issues and patents issued from 2005 to 2010 are also examined to identify consumer safety, product introduction, and product safety regulatory issues for stakeholders and potential stakeholders in this industry.
 
The report examines the cardiovascular surgery equipment industry in general, the types of technology currently in use as well as future applications, and regulatory influences. The industry structure section discusses the most active manufacturers with regard to relative market share, marketing strengths, and forces that promote or hamper growth of technologies. The technology sections detail historical, current, and projected (2010 through 2015) market values.
 
METHODOLOGY
 
BCC presents an analysis across the entire cardiovascular surgical device market based on reported revenue dollars and units shipped as reported to the Securities and Exchange Commission (SEC) and/or other governmental agencies, as well as company information such as annual reports and product/financial news releases.
 
We also analyze data gathered from the United States Patent Office (USPTO) databases. Technological and demographic information is gathered from industry sources, governmental sources, and published news reports.
 
INFORMATION SOURCES
 
BCC conducted primary and secondary research to develop this report. Sources included companies in the cardiovascular device market and supply industry, public documents, SEC filings, corporate white papers, and other technical documentation for U.S. and international companies directly involved in manufacturing and distributing of cardiovascular devices and related equipment. The report excludes resellers and retailers, focusing rather on the primary companies responsible for the development of the underlying technology.
 
Where precise information was not available, a consensus was made using reasonable assumptions and estimates based on historical data.
 
ANALYST CREDENTIALS
 
Peggy S. Lehr is the BCC Research Analyst of this report. Ms. Lehr has worked within the publishing arms of for-profit and not-for-profit organizations, with an emphasis on medical and nursing-related issues. She is the author of several BCC reports on the medical industry.
 
BCC ONLINE SERVICES
 
BCC offers an online information retrieval service. BCC’s home page, located at www.bccresearch.com, enables readers to:  
  • Examine BCC’s complete catalog of Market Research Reports and place direct orders
  • Subscribe to any of BCC’s many industry newsletters
  • Read announcements of recently published reports and newly launched newsletters
  • Register for BCC’s well-known conferences
  • Request additional information on any BCC product
  • Take advantage of special offers
DISCLAIMER
 
The information developed in this report is intended to be as reliable as possible at the time of publication and of a professional nature. This information does not constitute managerial, legal, or accounting advice; nor should it serve as a corporate policy guide, laboratory manual, or an endorsement of any product, as much of the information is speculative in nature. The author assumes no responsibility for any loss or damage that might result from reliance on the reported information or its use.
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW
Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
[+] Show Chapter Details
Title/Chapter NamePagesMember Price
Full Report: Cardiovascular Surgical Devices: The Global Market165Free
Chapter- 1: INTRODUCTION4Free
Chapter- 2: SUMMARY2Free
Chapter- 3: OVERVIEW OF THE INDUSTRY25Free
Chapter- 4: GLOBAL IMPLICATIONS OF CARDIOVASCULAR DISEASE AND CARDIOVASCULAR SURGERY14Free
Chapter- 5: GLOBAL MARKET FOR TRADITIONAL CARDIAC SURGERY DEVICES13Free
Chapter- 6: INTERVENTIONAL CARDIAC SURGERY DEVICES10Free
Chapter- 7: GLOBAL MARKET FOR CARDIAC RHYTHM MANAGEMENT DEVICES8Free
Chapter- 8: ONGOING DEVELOPMENT OF CARDIOVASCULAR DEVICES/TREATMENTS9Free
Chapter- 9: REIMBURSEMENT AND REGULATION ISSUES12Free
Chapter- 10: PATENT ANALYSIS15Free
Chapter- 11: COMPANY DIRECTORY53Free

Related Reports

Recent Reports

Surgical Equipment: Technologies and Global Markets

Published - Dec 2024 | Publisher - BCC Publishing | Code - HLC154C

The global market for surgical equipment and technologies was valued at $37.6 billion in 2023. This market is expected to grow from $40.0 billion in 2024 to $56.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2029.

Conventional and Alternative Pain Treatment Markets

Published - Nov 2024 | Publisher - Partha Sarathi Das | Code - HLC266B

The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.

CRISPR Technology: Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC258C

The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC239C

The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.

Medical Devices: Technologies and Global Markets

Published - Oct 2024 | Publisher - Partha Sarathi Das | Code - HLC170F

The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Top Trending Reports

Single-use Technologies for Biopharmaceuticals: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO099F

The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.

Cell and Gene Therapy Tools, and Reagents: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO208C

The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.

Medical Devices Industry: Competitive Landscape

Published - Nov 2024 | Publisher - BCC Publishing | Code - MDS010C

The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Global Market Opportunities and Competitive Landscape for CDMO

Published - Nov 2024 | Publisher - BCC Publishing | Code - PHM238B

The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC239C

The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Cardiovascular Surgical Devices: The Global Market
Customize This Report
Customize Report
Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.
Contact
© 2024 BCC Research
Privacy Policy |Site Map|Terms & Conditions